Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2026-06-13 @ 8:29 PM
Study NCT ID:
NCT04649151
Status:
COMPLETED
Last Update Posted:
2025-09-15
First Post:
2020-11-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19
Sponsor:
ModernaTX, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | SARS-CoV-2 | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | mRNA-1273 | View |
| None | mRNA-1273 vaccine | View |
| None | SARS-CoV-2 | View |
| None | SARS-CoV-2 Vaccine | View |
| None | mRNA-1273.222 vaccine | View |
| None | SARS-CoV-2 VOC | View |
| None | SARS-CoV-2 VOC vaccine | View |
| None | Omicron | View |
| None | Variant | View |
| None | Coronavirus | View |
| None | Virus Diseases | View |
| None | Messenger RNA | View |
| None | COVID-19 | View |
| None | COVID-19 Vaccine | View |
| None | Moderna | View |